Yong Man Kim

Also affiliated with University of Ulsan

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician’s Choice”.

Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician’s Choice

European Journal of Cancer(2023)10.1016/j.ejca.2023.03.015

N/A

0DataRank · unranked

17 citations

Nicoletta Colombo, Antonio Casado, Alessandro D. Santin, Émeline Colomba, David S. Miller +14 more

PARP inhibitors, use early in the first-line maintenance therapy setting but with caution

Annals of Translational Medicine(2023)10.21037/atm-2022-81

N/A

0DataRank · unranked

2 citations

Yong Man Kim, Jung‐Min Lee, Elena Giudice